Loading...
Market
What will be the primary focus of the next major research study on Lyme disease following the NIAID-funded genetic analysis by the end of 2024?
2
Resolution / Starting Odds
New treatments • 25%
Diagnostic tools • 25%
Vaccine development • 25%
Other • 25%
Scientific journal publications and research institution announcements
Story
NIAID-Funded Study Analyzes 47 Strains of Lyme Disease Bacteria to Advance Treatment
Aug 16, 2024, 01:00 PM
A new genetic analysis of Lyme disease-causing bacteria has been conducted by an international team of scientists, revealing the genetic makeup of 47 strains of known and potential bacteria responsible for the disease. This research, funded by the National Institute of Allergy and Infectious Diseases (NIAID), aims to improve the diagnosis and treatment of Lyme disease. The study provides insights into the history and future of Borrelia bacteria, which cause Lyme disease, and could significantly propel advancements in the field. The findings highlight the widespread nature of the tick-borne infection and offer potential pathways for developing new treatments.
View original story
Similar markets
Identification of new biomarkers • 25%
Development of new treatment protocols • 25%
Discovery of new disease pathways • 25%
No significant findings • 25%
Persistent viral RNA • 25%
T cell activation • 25%
Chronic inflammation • 25%
Other • 25%
Primarily Northeast US • 25%
Primarily Midwest US • 25%
Primarily West Coast US • 25%
Evenly distributed across US • 25%
Spike protein reduction • 25%
Immune modulation • 25%
Neurological symptom management • 25%
Other • 25%
Brain • 25%
Gut Wall • 25%
Spinal Cord • 25%
Other • 25%
0-2 • 25%
3-5 • 25%
6-8 • 25%
9 or more • 25%
Yes • 50%
No • 50%
Brain Fog • 25%
Fatigue • 25%
Inflammation • 25%
Other • 25%
Cancer Research • 25%
Infectious Diseases • 25%
Autoimmune Disorders • 25%
Neurodegenerative Diseases • 25%
Immune response • 25%
Viral persistence • 25%
Organ damage • 25%
Other • 25%